Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07144176
PHASE1
PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
Sponsor: Daewoong Pharmaceutical Co. LTD.
View on ClinicalTrials.gov
Summary
PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
Official title: An Open-label, Randomized, Fasting, Single-dose, Two-treatment, Two-period, Crossover, Phase 1 Clinical Trial to Compare and Evaluate the Pharmacokinetics and Safety of "DWJ1511" and "DWC202501" in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-09
Completion Date
2025-09
Last Updated
2025-08-28
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
DWJ1511
Test drug: DWJ1511
DRUG
DWC202501
Comparator: DWC202501
Locations (1)
H Plus Yangji Hospital
Seoul, South Korea